↓ Skip to main content

Dove Medical Press

Article Metrics

Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic

Overview of attention for article published in International Journal of Nanomedicine, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
30 Mendeley
Title
Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic
Published in
International Journal of Nanomedicine, February 2013
DOI 10.2147/ijn.s39072
Pubmed ID
Authors

Jong-Sang Park, An, Nam, Choi, Bai, Lee

Abstract

Glioma is still one of the most complicated forms of brain tumor to remove completely due to its location and the lack of an efficient means to specifically eliminate tumor cells. For these reasons, this study has examined the effectiveness of a nonviral gene therapy approach utilizing a tumor-selective killer gene on a brain tumor xenograft model.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 27%
Student > Master 5 17%
Student > Bachelor 3 10%
Student > Postgraduate 3 10%
Student > Doctoral Student 2 7%
Other 3 10%
Unknown 6 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 27%
Biochemistry, Genetics and Molecular Biology 6 20%
Medicine and Dentistry 5 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Chemical Engineering 1 3%
Other 2 7%
Unknown 7 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2013.
All research outputs
#15,265,264
of 22,699,621 outputs
Outputs from International Journal of Nanomedicine
#2,227
of 3,792 outputs
Outputs of similar age
#182,268
of 282,539 outputs
Outputs of similar age from International Journal of Nanomedicine
#43
of 77 outputs
Altmetric has tracked 22,699,621 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,792 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,539 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.